Work

The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation

Year: 2022

Type: review

Source: Clinics in Chest Medicine

DOI: 10.1016/j.ccm.2022.06.007

Authors: Lindsay J. Caverly, Sebastián A. Riquelme, Katherine B. Hisert

Institutions: University of Michigan, Michigan Medicine, Columbia University Irving Medical Center, Columbia University, National Jewish Health

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cystic Fibrosis Foundation, Vertex Pharmaceuticals, National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: The Role of Airway Microbiota in Nontuberculous Mycobacterial Infection in Cystic Fibrosis, Innate Immune Clearance of Host-Adapted Pulmonary Pathogens, G5017150260, G6757534204, Modulating macrophage-mediated Inflammation in cystic fibrosis, G7759666141, G8362211649, G8432459021, G8470278629, G8513730308

OpenAlex ID: W4308175332

FWCI: 2.034

Cites: 170

Cited by: 63

Related to: 10